Hca Healthcare, Inc. HCA
We take great care to ensure that the data presented and summarized in this overview for HCA Healthcare, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HCA
View all-
Vanguard Group Inc Valley Forge, PA17MShares$5.76 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY14.6MShares$4.93 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA11.5MShares$3.9 Billion0.7% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL11.4MShares$3.88 Billion6.37% of portfolio
-
State Street Corp Boston, MA8.55MShares$2.9 Billion0.13% of portfolio
-
First Eagle Investment Management, LLC4.5MShares$1.53 Billion3.44% of portfolio
-
Royal Bank Of Canada Toronto, A64.41MShares$1.5 Billion0.35% of portfolio
-
Geode Capital Management, LLC Boston, MA3.9MShares$1.32 Billion0.12% of portfolio
-
Bank Of America Corp Charlotte, NC3.6MShares$1.22 Billion0.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.1MShares$1.05 Billion0.13% of portfolio
Latest Institutional Activity in HCA
Top Purchases
Top Sells
About HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Insider Transactions at HCA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 17
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,861
-20.18%
|
$921,242
$322.86 P/Share
|
May 17
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,725
+15.1%
|
$552,825
$117.35 P/Share
|
May 16
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
3,204
-25.31%
|
$1,044,504
$326.3 P/Share
|
May 15
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
1,863
-8.68%
|
$607,338
$326.18 P/Share
|
May 15
2024
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,258
-34.68%
|
$6,930,108
$326.96 P/Share
|
May 15
2024
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,465
+28.56%
|
$2,959,875
$75.77 P/Share
|
May 15
2024
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,908
-42.57%
|
$3,230,008
$326.96 P/Share
|
May 15
2024
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+44.94%
|
$1,292,000
$68.96 P/Share
|
May 09
2024
|
Erol R Akdamar Group President |
BUY
Bona fide gift
|
Indirect |
5,139
+7.83%
|
-
|
May 09
2024
|
Erol R Akdamar Group President |
SELL
Bona fide gift
|
Direct |
5,139
-100.0%
|
-
|
May 09
2024
|
Jeffrey E. Cohen SVP-Government Relations |
SELL
Open market or private sale
|
Direct |
1,650
-24.14%
|
$516,450
$313.0 P/Share
|
May 09
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
6,311
-17.56%
|
$1,994,276
$316.88 P/Share
|
May 08
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Bona fide gift
|
Direct |
4,500
-11.13%
|
-
|
May 07
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,349
-23.4%
|
$3,877,586
$314.45 P/Share
|
May 07
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,660
+26.12%
|
$2,593,740
$139.06 P/Share
|
May 06
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,600
-4.48%
|
$494,400
$309.0 P/Share
|
May 03
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
890
-3.98%
|
$277,680
$312.0 P/Share
|
May 02
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
973
-4.17%
|
$303,576
$312.0 P/Share
|
May 01
2024
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Direct |
566
-20.19%
|
-
|
Apr 29
2024
|
Thomas F Frist Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,284
+8.69%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 212K shares |
---|---|
Exercise of conversion of derivative security | 187K shares |
Bona fide gift | 243K shares |
Payment of exercise price or tax liability | 178K shares |
---|---|
Bona fide gift | 250K shares |
Open market or private sale | 51K shares |